| Product name | Recombinant SARS-CoV-2 Nucleocapsid Protein |
|---|---|
| Catalog No. | RP01264LQ |
| Description | Recombinant SARS-CoV-2(2019-nCoV) Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala419) of SARS-COV-2(2019-nCoV) Nucleocapsid (Accession #QHD43423.2) fused with an 6×His tag at the N-terminus. |
| Bio-Activity | 1.Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Nucleocapsid at 2 μg/mL (100 μL/well) can bind Anti-Nucleocapsid antibody with a linear range of 0.12-1.64 ng/mL. 2.Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 envelope Protein at 2 μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 Nucleocapsid protein, the EC50 of Recombinant SARS-CoV-2 Nucleocapsid protein is 41.10 ng/mL. |
| Purity | > 95% by SDS-PAGE;> 95% by HPLC. |
| Endotoxin | < 1.0 EU/μg of the protein by LAL method. |
| Formulation | Supplied as a 0.22 μm filtered solution in 20mM Tris, 500mM NaCl, 0.1mM EDTA, 10% glycerol, pH8.0.Contact us for customized product form or formulation. |
| Species | SARS-CoV-2 |
| Calculated MW | 46.48 kDa |
| Synonym | Nucleoprotein |
|---|---|
| Expression Host | E. coli |
| Tag | N-His |
| Gene ID |
| Storage | Store at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles. |
|---|
* For research use only. Not for therapeutic or diagnostic purposes.
Publishing research using RP01264LQ? Please let us know so that we can cite the reference in this datasheet.
